한글목차

자궁내막증의 동향과 예측

세계의 자궁내막증 시장은 2024년부터 2030년까지 복합 연간 성장률(CAGR) 13.1%를 나타낼 전망이며 2030년에는 31억 달러에 달할 것으로 예측됩니다. 이 시장의 주요 촉진요인은 자궁내막증 연구를 위한 자금이 증가하고 있는 것, 감염증의 발생이나 유행성의 급증이 관찰되고 있는 것, 자궁내막증에 대한 의식이 높아지고 있어서 입니다. 세계의 자궁내막증 시장의 미래는 병원, 재택치료, 전문센터 시장에서의 기회에 의해 유망시되고 있습니다.

자궁내막증 시장 인사이트

Lucintel은 표재성 복막 병변의 유병률 증가 외에도 자궁 내막증에 대한 인식을 높이기위한 프로그램과 자궁 내막증 연구를위한 정부 자금 증가로 예측 기간 동안 표재성 복막 병변이 가장 높은 성장을 나타낼 것으로 예측됩니다.

병원은 병원 약국의 수가 증가하고 고품질의 서비스와 설비에 의한 병원에 대한 환자의 선호도가 증가함에 따라 가장 큰 부문로 계속 될 것으로 보입니다.

아시아태평양은 자궁내막증 환자의 유병률 증가와 이 지역 시장 진출 기업에 의한 전략적 노력 증가로 예측 기간 동안 가장 높은 성장이 예측됩니다.

이 보고서는 다음 11가지 주요 질문에 답변합니다.

• Q.1. 시장 부문 중 가장 유망하고 고성장하는 기회는 무엇인가?
• Q.2.향후 성장이 가속되는 부문과 그 이유는?
• Q.3. 앞으로 성장이 가속될 것으로 보이는 지역과 그 이유는?
• Q.4. 시장 역학에 영향을 미치는 주요 요인은? 시장의 주요 과제와 비즈니스 리스크는?
• Q.5. 이 시장에서의 비즈니스 리스크와 경쟁 위협은?
• Q.6. 이 시장에서의 새로운 동향과 그 이유는?
• Q.7. 시장에서 고객 수요 변화에는 어떤 것이 있는가?
• Q.8. 이 시장에서의 새로운 개발과 그 개발을 리드하고 있는 기업은?
• Q.9.이 시장의 주요 기업은? 주요 기업은 사업 성장을 위해 어떤 전략적 노력을 추진하고 있는가?
• Q.10. 이 시장에서 경쟁 제품은 어떠한 것이며, 재료 및 제품의 대체로 인한 시장 점유율 저하의 위협은 어느 정도입니까?
• Q.11. 지난 5년 동안 어떤 M&D가 수행되었고 업계에 어떤 영향을 미쳤는가?

목차

제1장 주요 요약

제2장 세계의 자궁내막증 시장 : 시장 역학

• 소개, 배경, 분류
• 공급망
• 업계의 촉진요인과 과제

제3장 2018년부터 2030년까지 시장 동향과 예측 분석

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 자궁내막증 시장 동향(2018-2023)과 예측(2024-2030)
• 유형별 세계의 자궁내막증 시장
  • 표재성 복막 병변
  • 자궁내막종
  • 기타
• 유통채널별 세계의 자궁내막증 시장
  • 병원 약국
  • 온라인 약국
  • 소매 약국
• 치료별 세계의 자궁내막증 시장
  • 경구 피임약
  • 성선 자극 호르몬 방출 호르몬(GnRH) 약물
  • 기타
• 최종 이용 산업별 세계의 자궁내막증 시장
  • 병원
  • 홈케어
  • 전문센터
  • 기타

제4장 2018년부터 2030년까지 지역별 시장 동향과 예측 분석

• 지역별 세계의 자궁내막증 시장
• 북미의 자궁내막증 시장
• 유럽의 자궁내막증 시장
• 아시아태평양자궁내막증시장
• 기타 지역 자궁 내막증 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영상의 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략적 분석

• 성장 기회 분석
  • 유형별 세계의 자궁내막증 시장의 성장 기회
  • 유통 채널별 세계의 자궁내막증 시장의 성장 기회
  • 치료법별 세계의 자궁내막증 시장의 성장 기회
  • 최종 이용 산업별 세계의 자궁내막증 시장의 성장 기회
  • 지역별 세계의 자궁내막증 시장의 성장 기회
• 세계의 자궁내막증 시장의 새로운 동향
• 전략적 분석
  • 신제품 개발
  • 세계의 자궁내막증 시장의 능력 확대
  • 세계의 자궁내막증 시장에서의 합병, 인수, 합작 사업
  • 인증 및 라이센스

제7장 유력 기업의 기업 프로파일

• Consilient Health
• Sun Pharmaceutical
• Sanofi
• AstraZeneca
• Serum Institute of India
• Pfizer
• Teva Pharmaceutical Industries
• GlaxoSmithKline
• Merck
• Abbott Laboratories

영문목차

Endometriosis Trends and Forecast

The future of the global endometriosis market looks promising with opportunities in the hospital, homecare, and speciality center markets. The global endometriosis market is expected to reach an estimated $3.1 billion by 2030 with a CAGR of 13.1% from 2024 to 2030. The major drivers for this market are increasing funding for endometriosis research, surge in infectious disease outbreaks and pandemics is observed, and growing awareness towards endometriosis.

A more than 150-page report is developed to help in your business decisions.

Endometriosis by Segment

The study includes a forecast for the global endometriosis by type, distribution channel, treatment, end use industry, and region.

Endometriosis Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Superficial Peritoneal Lesion
• Endometriomas
• Others

Endometriosis Market by Distribution channel [Shipment Analysis by Value from 2018 to 2030]:

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Endometriosis Market by Treatment [Shipment Analysis by Value from 2018 to 2030]:

• Oral Contraceptives
• Gonadotropin-Releasing Hormone (GnRH) Medicines
• Others

Endometriosis Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals
• Homecare
• Speciality Centers
• Others

Endometriosis Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Endometriosis Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies endometriosis companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the endometriosis companies profiled in this report include-

• Consilient Health
• Sun Pharmaceutical
• Sanofi
• Astrazeneca
• Serum Institute Of India
• Pfizer
• Teva Pharmaceutical Industries
• Glaxosmithkline
• Merck
• Abbott Laboratories

Endometriosis Market Insights

Lucintel forecasts that superficial peritoneal lesion is expected to witness highest growth over the forecast period due to the rising prevalence of superficial peritoneal lesions, coupled with programs aimed at boosting endometriosis awareness and increased government funding for endometriosis research.

Hospitals will remain the largest segment due to the increase in the number of hospital pharmacies and growing patient preference for hospitals due to their high-quality services and facilites.

APAC is expected to witness highest growth over the forecast period due to the increasing prevalence of endometriosis cases and rising number of strategic intiatives by market players in the region.

Features of the Global Endometriosis Market

Market Size Estimates: Endometriosis market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Endometriosis market by various segments, such as by type, distribution channel, treatment, end use industry and region in terms of($B).

Regional Analysis: Endometriosis market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, distribution channels, treatments, end use industries, and region.s for the endometriosis market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the endometriosis market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the endometriosis market size?

Answer: The global endometriosis market is expected to reach an estimated $3.1 billion by 2030.

Q.2. What is the growth forecast for endometriosis market?

Answer: The global endometriosis market is expected to grow with a CAGR of 13.1% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the endometriosis market?

Answer: The major drivers for this market are increasing funding for endometriosis research, surge in infectious disease outbreaks and pandemics is observed, and growing awareness towards endometriosis.

Q.4. What are the major segments for endometriosis market?

Answer: The future of the endometriosis market looks promising with opportunities in the hospital, homecare, and speciality center markets.

Q.5. Who are the key Endometriosis Market companies?

Answer: Some of the key endometriosis companies are as follows:

• Consilient Health
• Sun Pharmaceutical
• Sanofi
• AstraZeneca
• Serum Institute of India
• Pfizer
• Teva Pharmaceutical Industries
• GlaxoSmithKline
• Merck
• Abbott Laboratories

Q.6. Which endometriosis market segment will be the largest in future?

Answer: Lucintel forecasts that superficial peritoneal lesion is expected to witness highest growth over the forecast period due to the rising prevalence of superficial peritoneal lesions, coupled with programs aimed at boosting endometriosis awareness and increased government funding for endometriosis research.

Q.7. In endometriosis market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to the increasing prevalence of endometriosis cases and rising number of strategic intiatives by market players in the region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the endometriosis market by type (superficial peritoneal lesion, endometriomas, and others), distribution channel (hospital pharmacy, online pharmacy, and retail pharmacy), treatment (oral contraceptives, gonadotropin-releasing hormone (GnRH) medicines, and others), end use industry (hospitals, homecare, speciality centers, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Endometriosis Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Endometriosis Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Endometriosis Market by Type
  • 3.3.1: Superficial Peritoneal Lesion
  • 3.3.2: Endometriomas
  • 3.3.3: Others
• 3.4: Global Endometriosis Market by Distribution channel
  • 3.4.1: Hospital Pharmacy
  • 3.4.2: Online Pharmacy
  • 3.4.3: Retail Pharmacy
• 3.5: Global Endometriosis Market by Treatment
  • 3.5.1: Oral Contraceptives
  • 3.5.2: Gonadotropin-Releasing Hormone (GnRH) Medicines
  • 3.5.3: Others
• 3.6: Global Endometriosis Market by End Use Industry
  • 3.6.1: Hospitals
  • 3.6.2: Homecare
  • 3.6.3: Speciality Centers
  • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Endometriosis Market by Region
• 4.2: North American Endometriosis Market
  • 4.2.2: North American Endometriosis Market by End Use Industry: Hospitals, Homecare, Speciality Centers, and Others
• 4.3: European Endometriosis Market
  • 4.3.1: European Endometriosis Market by Type: Superficial Peritoneal Lesion, Endometriomas, and Others
  • 4.3.2: European Endometriosis Market by End Use Industry: Hospitals, Homecare, Speciality Centers, and Others
• 4.4: APAC Endometriosis Market
  • 4.4.1: APAC Endometriosis Market by Type: Superficial Peritoneal Lesion, Endometriomas, and Others
  • 4.4.2: APAC Endometriosis Market by End Use Industry: Hospitals, Homecare, Speciality Centers, and Others
• 4.5: ROW Endometriosis Market
  • 4.5.1: ROW Endometriosis Market by Type: Superficial Peritoneal Lesion, Endometriomas, and Others
  • 4.5.2: ROW Endometriosis Market by End Use Industry: Hospitals, Homecare, Speciality Centers, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Endometriosis Market by Type
  • 6.1.2: Growth Opportunities for the Global Endometriosis Market by Distribution channel
  • 6.1.3: Growth Opportunities for the Global Endometriosis Market by Treatment
  • 6.1.4: Growth Opportunities for the Global Endometriosis Market by End Use Industry
  • 6.1.5: Growth Opportunities for the Global Endometriosis Market by Region
• 6.2: Emerging Trends in the Global Endometriosis Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Endometriosis Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Endometriosis Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Consilient Health
• 7.2: Sun Pharmaceutical
• 7.3: Sanofi
• 7.4: AstraZeneca
• 7.5: Serum Institute of India
• 7.6: Pfizer
• 7.7: Teva Pharmaceutical Industries
• 7.8: GlaxoSmithKline
• 7.9: Merck
• 7.10: Abbott Laboratories